-
1
-
-
38049170879
-
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: A prospective randomised controlled study
-
L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomised controlled study Fertil. Steril. 89 2008 84 91
-
(2008)
Fertil. Steril.
, vol.89
, pp. 84-91
-
-
Engmann, L.1
Diluigi, A.2
Schmidt, D.3
Nulsen, J.4
Maier, D.5
Benadiva, C.6
-
2
-
-
75749138165
-
1500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin- releasing hormone agonist is used for ovulation induction: A prospective, randomized, controlled study
-
P. Humaidan, H.E. Bredkjaer, L.G. Westergaard, and C.Y. Andersen 1500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin- releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil. Steril. 93 2010 847 854
-
(2010)
Fertil. Steril.
, vol.93
, pp. 847-854
-
-
Humaidan, P.1
Bredkjaer, H.E.2
Westergaard, L.G.3
Andersen, C.Y.4
-
3
-
-
84856667547
-
The luteal phase after GnRH-agonist triggering of ovulation: Present and future perspectives
-
P. Humaidan, E.G. Papanikolaou, D. Kyrou, B. Alsbjerg, N.P. Polyzos, P. Devroey, and H.M. Fatemi The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives Reprod. Biomed. Online 24 2012 134 141
-
(2012)
Reprod. Biomed. Online
, vol.24
, pp. 134-141
-
-
Humaidan, P.1
Papanikolaou, E.G.2
Kyrou, D.3
Alsbjerg, B.4
Polyzos, N.P.5
Devroey, P.6
Fatemi, H.M.7
-
4
-
-
14044276987
-
Can we eliminate ovarian hyperstimulation syndrome?
-
R. Orvieto Can we eliminate ovarian hyperstimulation syndrome? Hum. Reprod. 20 2005 320 322
-
(2005)
Hum. Reprod.
, vol.20
, pp. 320-322
-
-
Orvieto, R.1
-
5
-
-
33747065541
-
Substituting HCG with GnRH agonist to trigger final follicular maturation - A retrospective comparison of three different ovarian stimulation protocols
-
R. Orvieto, J. Rabinson, S. Meltzer, E. Zohav, E. Anteby, and R. Homburg Substituting HCG with GnRH agonist to trigger final follicular maturation-a retrospective comparison of three different ovarian stimulation protocols Reprod. Biomed. Online 13 2006 198 201
-
(2006)
Reprod. Biomed. Online
, vol.13
, pp. 198-201
-
-
Orvieto, R.1
Rabinson, J.2
Meltzer, S.3
Zohav, E.4
Anteby, E.5
Homburg, R.6
-
6
-
-
79951945981
-
A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: A randomized prospective proof of concept study
-
E.G. Papanikolaou, W. Verpoest, H. Fatemi, B. Tarlatzis, P. Devroey, and H. Tournaye A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study Fertil. Steril. 95 2011 1174 1177
-
(2011)
Fertil. Steril.
, vol.95
, pp. 1174-1177
-
-
Papanikolaou, E.G.1
Verpoest, W.2
Fatemi, H.3
Tarlatzis, B.4
Devroey, P.5
Tournaye, H.6
|